NCT05163600

Brief Summary

The investigators hypothesize that BFR exercise regimens result in a different acute cardiorespiratory response pattern compared to traditional exercise regimens. Furthermore, the investigators hypothesize that these patterns differ between healthy participants and participants with COPD. Regarding secondary objective, the investigators hypothesize that BFR results in lower blood pressure responses compared to traditional exercise training in both healthy and COPD participants.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
May 2022Dec 2026

First Submitted

Initial submission to the registry

December 3, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 20, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

May 20, 2022

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 7, 2026

Status Verified

July 1, 2026

Enrollment Period

4.6 years

First QC Date

December 3, 2021

Last Update Submit

July 3, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Endurance Exercise:(Fixed-Duration Protocol):

    Minute ventilation (VE) will be continuously assessed during cycling exercise across all conditions to evaluate ventilatory demand.

    Continuously during exercise and at end of exercise, with recovery measurements obtained within 4 minutes post-exercise

  • Resistance Exercise - Healthy Participants (LOP Comparison Arm): Within-subject difference change in Maximal Voluntary Contraction (MVC)

    Maximal voluntary contraction (MVC) of the knee extensors will be assessed before and immediately after unilateral leg press exercise performed with blood flow restriction at 40% and 80% limb occlusion pressure (LOP). MVC will be measured using an isometric setup, and voluntary activation will be evaluated using the twitch interpolation technique with supramaximal electrical stimulation. The primary outcome is the change in MVC from pre- to post-exercise, reflecting exercise-induced neuromuscular fatigue.

    Pre-exercise and immediately post-exercise (within minutes after completion of the exercise protocol)

  • Endurance Exercise - COPD Participants (Exhaustive Protocol): Within-subject difference in maximal minute ventilation (VE) between BFR and traditional exercise regimens

    Minute ventilation (VE) will be continuously assessed during cycling exercise across all conditions to evaluate ventilatory demand and response.

    Continuously during exercise, at end of exercise (peak value), and within 4 minutes post-exercise

  • Resistance Exercise:(Healthy and COPD): Ventilatory Response (Ventilation, VE)

    Minute ventilation (VE) will be continuously assessed during cycling exercise across all conditions to evaluate ventilatory demand.

    Continuously during exercise and at end of exercise, with recovery measurements obtained within 4 minutes post-exercise

Secondary Outcomes (11)

  • Resistance Exercise - Healthy Participants (LOP Comparison Arm): Muscle Oxygenation (NIRS)

    Continuously during exercise and immediately post-exercise

  • Resistance Exercise - Healthy Participants (LOP Comparison Arm): Perceived Exertion / Dyspnea (Borg Scale)

    At baseline (pre-exercise), after each set, immediately post-exercise, and at 2 and 4 minutes post-exercise

  • Endurance Exercise - COPD Participants (Exhaustive Protocol): Cardiorespiratory Response (Vo2 , VCO2)

    Continuously during exercise and at end of exercise, with recovery measurements obtained within 4 minutes post-exercise

  • Endurance Exercise - COPD Participants (Exhaustive Protocol):NIRS

    Continuously during exercise and at end of exercise, with recovery measurements obtained within 4 minutes post-exercise

  • Endurance Exercise - COPD Participants (Exhaustive Protocol): Blood Lactate Concentration

    At baseline (pre-exercise) at peak and 3 min wpost-exercise

  • +6 more secondary outcomes

Study Arms (4)

Endurance Exercise - COPD and Healthy Participants (Fixed-Duration Protocol)

EXPERIMENTAL

Both COPD patients and healthy participants will complete two endurance exercise conditions in a randomized, crossover design: * Blood Flow Restriction Cycling (BFR-CYC) * Non-BFR Control Cycling BFR-CYC: Three intervals of 2 minutes at 50% PWR, separated by 1-minute recovery periods, with bilateral thigh cuffs inflated to 50% LOP during exercise intervals. Control: Time- and structure-matched protocol (3 × 2 minutes) without blood flow restriction at 65% PWR, with identical recovery periods.

Other: BFR-CYC 3x2min

Resistance Exercise - COPD and Healthy Participants (BFR vs Control, Fixed Protocol)

EXPERIMENTAL

Both COPD patients and healthy participants will complete two resistance exercise conditions in a randomized, crossover design: * Blood Flow Restriction Resistance Exercise (BFR-RE) * Non-BFR Control Resistance Exercise BFR-RE: Unilateral right-leg press at 40% of one-repetition maximum (1RM) with cuffs inflated to 80% LOP. Protocol: 4 sets (30-15-15-15 repetitions). Control: Bilateral leg press at 40% 1RM, 3 sets of 15 repetitions, without blood flow restriction.

Other: BFR Resistance 80% LOP

Endurance Exercise - COPD Participants (Exhaustive Protocol)

EXPERIMENTAL

Patients with COPD will complete three cycling exercise conditions in a randomized, crossover design: * Blood Flow Restriction Cycling (BFR-CYC) * Continuous Cycling (CONT-CYC) * Interval Cycling (INT-CYC)

Other: BFR-CYC 50% peak / 50% AOP (exhaustive)

Resistance Exercise - Healthy Participants (LOP Comparison Arm)

EXPERIMENTAL

Healthy participants will complete two BFR resistance exercise conditions in a randomized, crossover design: * BFR at 40% LOP * BFR at 80% LOP Participants will perform unilateral right-leg press exercise at 40% 1RM using a standardized protocol of 4 sets (30-15-15-15 repetitions) with fixed rest intervals. The protocol will be completed as prescribed (not to volitional exhaustion) unless predefined safety criteria require early termination.

Other: BFR REsistance 48% vs. 80% LOP

Interventions

BFR-CYC: Continuous cycling at 50% peak work rate (PWR) with bilateral thigh cuffs inflated to 50% limb occlusion pressure (LOP). A maximum duration of 30 minutes is applied as a safety limit.

Endurance Exercise - COPD Participants (Exhaustive Protocol)

BFR-CYC: Three intervals of 2 minutes at 50% PWR, separated by 1-minute recovery periods, with bilateral thigh cuffs inflated to 50% LOP during exercise intervals.

Endurance Exercise - COPD and Healthy Participants (Fixed-Duration Protocol)

BFR-RE: Unilateral right-leg press at 40% of one-repetition maximum (1RM) with cuffs inflated to 80% LOP. Protocol: 4 sets (30-15-15-15 repetitions).

Resistance Exercise - COPD and Healthy Participants (BFR vs Control, Fixed Protocol)

* BFR at 40% LOP * BFR at 80% LOP All sessions will be conducted on a leg press device under standardized laboratory conditions. Pneumatic cuffs will be applied to the proximal thigh of the right leg. Participants will perform unilateral right-leg press exercise at 40% 1RM using a standardized protocol of 4 sets (30-15-15-15 repetitions) with fixed rest intervals. The protocol will be completed as prescribed (not to volitional exhaustion) unless predefined safety criteria require early termination.

Resistance Exercise - Healthy Participants (LOP Comparison Arm)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Clinically healthy

You may not qualify if:

  • Physical or intellectual impairment precluding informed consent or protocol adherence
  • Non-German speaking (precluding informed consent)
  • Pain during exercise of any origin
  • Pregnancy
  • History of thromboembolic event in the lower extremity
  • Resting systolic blood pressure \<100 mmHg
  • Age ≥ 18 years
  • Diagnosed COPD according to GOLD-guidelines12
  • Physical or intellectual impairment precluding informed consent or protocol adherence
  • Non-German speaking (precluding informed consent)
  • Acute or recent (within the last 6 weeks) exacerbation of COPD
  • Pain during exercise of any origin
  • Pregnancy
  • History of thromboembolic event in the lower extremity
  • Resting systolic blood pressure \<100 mmHg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zürich

Zurich, Canton of Zurich, 8091, Switzerland

RECRUITING

Related Publications (1)

  • Kuhn M, Clarenbach CF, Klay A, Kohler M, Mayer LC, Luchinger M, Andrist B, Radtke T, Haile SR, Sievi NA, Kohlbrenner D. Exploring immediate cardiorespiratory responses: low-intensity blood flow restricted cycling vs. moderate-intensity traditional exercise in a randomized crossover trial. BMC Sports Sci Med Rehabil. 2024 Aug 15;16(1):172. doi: 10.1186/s13102-024-00951-0.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Christian Clarenbach, Dr. med

    University of Zurich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christan Clarenbach, Dr. med

CONTACT

Manuel Kuhn, PhD Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: monocenter / multicenter with a new study arm
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PD Dr. med Head of Pneumology

Study Record Dates

First Submitted

December 3, 2021

First Posted

December 20, 2021

Study Start

May 20, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 7, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations